Senior insider sale
Chief Medical Officer at ROCKET PHARMACEUTICALS, INC. — senior position signals high conviction
$15.2K
5.03K shares
What this filing means
SCHWARTZ JONATHAN DAVID plans to sell 5.03K shares of ROCKET PHARMACEUTICALS, INC. valued at approximately $15.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/18/2025ACC: 0001959173-25-007115
Officer· Chief Medical Officer
Since Jan 2019
5.03K
Shares to sell
$15.2K
Approx. market value
2.54K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
11/14/2025
2.54KTotal acquired2.54K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/14/2025 | Restricted Stock Vesting Compensation | 2.54K | — |
| Total | 2.54K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
805.00
Market value
$2.4K
8/19/2025
—Completed
Units to sell
1.68K
Market value
$5.1K
8/18/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.54K
Market value
$7.6K
11/18/2025
Total
Units
5.03K
Value
$15.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/19/2025 | 805.00 | $2.4K | — | Completed |
8/18/2025 | 1.68K | $5.1K | — | Completed |
| Planned — Approximate Date | ||||
11/18/2025 | 2.54K | $7.6K | NASDAQ | Planned |
| Total | 5.03K | $15.2K | ||